Prelude Therapeutics Inc (PRLD) Insider Ownership

Historic Insider Ownership Trends

PRLD's three largest insider shareholders as of May 14, 2026 are Krishna Vaddi (Ceo, 2.00Mn shares), Krishna Vaddi (Ceo, 2.00Mn shares), David P Bonita (Director, 1.13Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Krishna Vaddi Ceo 1,999,296 0 27 Mar, 2025
Krishna Vaddi Ceo 1,999,296 0 27 Mar, 2025
David P Bonita - 0 1,126,126 23 Apr, 2026
Advisors Llc Orbimed - 0 1,126,126 23 Apr, 2026
Andrew Combs Chief Chemistry Officer 480,123 0 27 Mar, 2025
Peggy Scherle Chief Scientific Officer 172,920 0 30 Aug, 2021
Peggy Scherle Chief Scientific Officer 172,920 0 30 Aug, 2021
Krishna Vaddi Ceo 0 142,553 03 Jan, 2025
Krishna Vaddi Ceo 0 142,553 03 Jan, 2025
Krishna Vaddi Ceo 0 120,665 21 Dec, 2022
Krishna Vaddi Ceo 0 120,665 21 Dec, 2022
Jane Huang President, Cmo 86,917 0 07 Oct, 2025
Laurent Chardonnet Chief Financial Officer 42,165 0 25 May, 2023
Bryant David Lim Clo, Interim Cfo, Corp Sec. 27,400 0 20 Dec, 2024
Christopher Pierce Evp And Chief Of Business Oper 3,750 0 07 Sep, 2021
Deborah Morosini Evp, Chief Of Clinical Affairs 444 0 17 Dec, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
21 Apr, 2026 David P Bonita Common Stock A 1,689,189 $4.44 11,808,945 I P
21 Apr, 2026 Advisors Llc Orbimed Common Stock A 1,689,189 $4.44 11,808,945 I P
21 Apr, 2026 Advisors Llc Orbimed Common Stock A 1,689,189 $4.44 11,808,945 I P
21 Apr, 2026 David P Bonita Common Stock A 1,689,189 $4.44 11,808,945 I P
21 Apr, 2026 David P Bonita Common Stock A 1,689,189 $4.44 11,808,945 I P
21 Apr, 2026 Advisors Llc Orbimed Common Stock A 1,689,189 $4.44 11,808,945 I P
21 Apr, 2026 David P Bonita Common Stock A 1,689,189 $4.44 11,808,945 I P
21 Apr, 2026 Advisors Llc Orbimed Common Stock A 1,689,189 $4.44 11,808,945 I P
21 Apr, 2026 David P Bonita Common Stock A 1,689,189 $4.44 11,808,945 I P
21 Apr, 2026 Advisors Llc Orbimed Common Stock A 1,689,189 $4.44 11,808,945 I P
21 Apr, 2026 David P Bonita Common Stock A 1,126,126 $4.44 1,126,126 I P
21 Apr, 2026 Advisors Llc Orbimed Common Stock A 1,126,126 $4.44 1,126,126 I P
21 Apr, 2026 David P Bonita Common Stock A 1,126,126 $4.44 1,126,126 I P
21 Apr, 2026 Advisors Llc Orbimed Common Stock A 1,126,126 $4.44 1,126,126 I P
21 Apr, 2026 Advisors Llc Orbimed Common Stock A 1,126,126 $4.44 1,126,126 I P
21 Apr, 2026 David P Bonita Common Stock A 1,126,126 $4.44 1,126,126 I P
21 Apr, 2026 David P Bonita Common Stock A 1,126,126 $4.44 1,126,126 I P
21 Apr, 2026 Advisors Llc Orbimed Common Stock A 1,126,126 $4.44 1,126,126 I P
21 Apr, 2026 Advisors Llc Orbimed Common Stock A 1,126,126 $4.44 1,126,126 I P
21 Apr, 2026 David P Bonita Common Stock A 1,126,126 $4.44 1,126,126 I P